rubella virus vaccine - injection, Meruvax II
GENERIC NAME: RUBELLA VIRUS VACCINE - INJECTION (roo-BEL-a)
BRAND NAME(S): Meruvax II
USES: This medication is used to help prevent infection from the rubella virus. Rubella (also known as German measles) is a common childhood infection. It may rarely cause problems in children. However, rubella infection in a pregnant woman may cause the unborn infant to die before birth or be born with physical defects. Vaccination during childhood can prevent these infections so that pregnant mothers who have never had rubella or been vaccinated are not exposed to rubella by others (e.g., their other children).The rubella virus in this vaccine is alive, but it has been weakened (attenuated) so that it has a decreased ability to cause illness. This vaccine causes the body to make immune defensive substances (antibodies) against the rubella virus so that you will be protected from this infection.The vaccine is recommended for all children 12 months and older and adults who have not already had rubella or been vaccinated.
Report Problems to the Food and Drug Administration
You are encouraged to report negative side effects of prescription drugs to the FDA. Visit the FDA MedWatch website or call 1-800-FDA-1088.
Need help identifying pills and medications?
Back to Medications Index
- Allergic Skin Disorders
- Bacterial Skin Diseases
- Bites and Infestations
- Diseases of Pigment
- Fungal Skin Diseases
- Medical Anatomy and Illustrations
- Noncancerous, Precancerous & Cancerous Tumors
- Oral Health Conditions
- Papules, Scales, Plaques and Eruptions
- Scalp, Hair and Nails
- Sexually Transmitted Diseases (STDs)
- Vascular, Lymphatic and Systemic Conditions
- Viral Skin Diseases
- Additional Skin Conditions